Heather van Raalte, MD
Gynecology · Princeton, NJNPI 1285660183
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (43.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Coloplast accounts for 92.7% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2019 at $58,831 and has fallen 76.4% since, to $13,875 in 2025. Among gynecology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 444 payments — averaging $315.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$130K
- Laborie Medical Technologies Corp.$3K
- Axonics, Inc.$3K
- AbbVie$2K
- Boston Scientific$986
- Pfizer$284
- plus $2K from 23 others
Across 1 payment — averaging $4350.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pelvalon Inc.$4K
What the payments were for
- Consulting fees$40,97429%
- Speaking & faculty fees$2,8002%
- Travel & lodging$26,33919%
- Food & beverage$9,2827%
- Education$60,59343%
- Gifts$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 221 | $129,837 |
| Laborie Medical Technologies Corp. | 3 | $2,816 |
| Axonics, Inc. | 53 | $2,675 |
| AbbVie(2 entities) | 68 | $1,544 |
| Boston Scientific | 6 | $986 |
| Pfizer | 23 | $284 |
| Caldera Medical, Inc | 6 | $234 |
| Medtronic(2 entities) | 6 | $231 |
| Astellas Pharma US Inc | 15 | $230 |
| Intuitive Surgical | 6 | $195 |
| Escala Medical Inc. | 2 | $183 |
| Baxter Healthcare | 1 | $133 |
| Therapeuticsmd, Inc. | 8 | $110 |
| Femselect Inc. | 1 | $104 |
| Sumitomo Pharma America, Inc. | 4 | $65 |
| AMAG Pharmaceuticals, Inc. | 4 | $55 |
| Johnson & Johnson | 2 | $52 |
| Avanos Medical | 2 | $45 |
| Mission Pharmacal Company | 2 | $36 |
| Bluewind Medical | 1 | $30 |
| Contura, Inc. | 1 | $30 |
| Scynexis, Inc. | 2 | $29 |
| Urocure LLC | 1 | $25 |
| Dentsply IH Inc. | 1 | $18 |
| Biocompatibles, Inc. | 1 | $16 |
| Avadel Specialty Pharmaceuticals, LLC | 1 | $15 |
| Avation Medical, Inc. | 1 | $14 |
| Urovant Sciences Inc | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$117,001
- TITAN$3,959
- Bulkamid$1,802
- Axonics$1,683
- RESTORELLE$1,565
- BOTOX$731
- Saffron$715
- AXIS$374
- Advantage System$360
- SOLYX$300
- Sonicision$150
- Axonics r-SNM System$144
- STARLING SYSTEM$133
- Solyx SIS System$114
- EnPlace$104
How this compares
$140,017 in reported general payments places this provider in the 95th percentile of 97 gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 321 | $268,378 |
| MyrbetriqMirabegron | 370 | $262,136 |
| Estradiol | 458 | $33,365 |
| PremarinEstrogens, Conjugated | 57 | $25,587 |
| ImvexxyEstradiol | 25 | $13,854 |
| Methenamine Hippurate | 115 | $10,221 |
| EstringEstradiol | 14 | $8,271 |
| OsphenaOspemifene | 12 | $7,284 |
| Mirabegron ErMirabegron | 15 | $7,238 |
| YuvafemEstradiol | 44 | $5,960 |
| Trospium Chloride ErTrospium Chloride | 35 | $5,696 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 226 | $2,372 |
| Trospium Chloride | 47 | $2,369 |
| Solifenacin Succinate | 39 | $1,494 |
| NitrofurantoinNitrofurantoin Macrocrystal | 44 | $1,223 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $65 | $268,378321 claims |
| Astellas Pharma US IncMyrbetriq | $230 | $262,136370 claims |
| PfizerPremarin, Estring | $284 | $33,85871 claims |
| Therapeuticsmd, Inc.Imvexxy | $110 | $13,85425 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 97 gynecology providers in New Jersey.
Other gynecology in Princeton
- Scott EderPrinceton$124K
- Maria SophoclesPrinceton$5K
- James TursiLumberton$217K
- Marco PelosiBayonne$164K
- Michael VardyEnglewood$114K
- Daryl BoffardUnion$55K
- Shyama MathewsPlainsboro$54K
- Lora LiuJersey City$36K
- Mark EinsteinNewark$27K
- Jessica Opoku-AnaneNew Brunswick$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.